Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2023-08-01Clinical Trial Update: Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers [NA]
Feasibility and preliminary efficacy study of a mindfulness-based intervention for children and young adults with high-grade or high-risk ca…
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome [NA]
An update on a matched targeted therapy trial for high-risk leukemias and myelodysplastic syndrome; results have been posted and the study i…
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant [Phase 3]
Phase 3 trial evaluating whether Lactobacillus plantarum can prevent acute graft-versus-host disease in children undergoing donor stem cell …
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning [Phase 2]
Phase 2 trial update on allogeneic transplantation using timed sequential busulfan and fludarabine conditioning for various hematologic mali…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia [Phase 2]
Phase 2 clinical trial update for venetoclax combined with IM2 in relapsed/refractory T lymphoblastic lymphoma/leukemia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating alemtuzumab plus peripheral stem cell transplantation in patients with leukemia.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating high-dose cyclophosphamide, tacrolimus, and mycophenolate mofetil to prevent graft-versus-host disease in …
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders [Phase 2]
Phase 2 clinical trial update on donor peripheral stem cell transplantation for patients with advanced hematologic cancers and related disor…
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial update evaluating a conditioning regimen of Helical Tomotherapy with fludarabine phosphate and melphalan foll…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating CD19 and CD22 targeted CAR-T therapy for relapsed/refractory B-cell leukemia and lymphoma with safety and efficac…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial update evaluating a CD19-targeted CAR-T therapy for relapsed/refractory CD19-positive B cell leukemia and lymphom…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update for a CD19-targeted CAR-T cell therapy in relapsed/refractory CD19+ B-cell leukemias and lymphomas.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders [NA]
This clinical trial update reports on allogeneic hematopoietic cell transplantation from matched unrelated donors in patients with advanced …
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT [Phase 2, Phase 3]
Phase 2/Phase 3 trial assessing CD45RA-depleted T-cell infusion to prevent infections after TCRab/CD19-depleted allogeneic hematopoietic ste…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia [Phase 2]
Phase II study evaluating allogeneic stem cell transplantation in patients with active acute leukemia has been completed.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures [Phase 4]
Phase 4 trial comparing EMLA cream to lidocaine injection for pain control during lumbar punctures in pediatric oncology patients.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia [Phase 2, Phase 3]
Clinical trial comparing M-PTCy to BuCy in haploidentical HSCT for acute leukemia across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT. [Phase 2]
A Phase 2 single-arm trial evaluating prophylactic tocilizumab to prevent acute graft-versus-host disease after haploidentical hematopoietic…
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation [Phase 4]
Phase 4 clinical study evaluating individualized administration of anti-thymocyte globulin (rATG) in haploidentical hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation [Phase 2]
Phase 2 trial comparing bulk versus fractionated stem cell infusions in patients with leukemia undergoing stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2022-12-27Clinical Trial Update: Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating clofarabine, melphalan, and thiotepa followed by donor stem cell transplant for high-risk hematologic …
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan [Phase 2]
Phase II trial evaluating allogeneic hematopoietic cell transplantation for B-cell non-Hodgkin lymphoma using Zevalin, fludarabine, and melp…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. [Phase 2]
Phase 2 trial update on conditioning regimens for transplantation of unrelated donor umbilical cord blood in patients with hematologic malig…
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy [Phase 2]
Phase 2 clinical trial of haploidentical donor hematopoietic progenitor cell and natural killer (NK) cell transplantation for hematologic ma…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS [Phase 3]
Phase 3 trial comparing NiCord (omidubicel) stem cell transplantation to standard umbilical cord blood in patients with hematologic malignan…